Vivo Bio Tech quarterly results and financials

Vivo Bio Tech (BSE 511509)₹16.80+1.88%(25 Sept 2026 close)Biotechnology

Key facts

In the Jun 2026 quarter (consolidated), Vivo Bio Tech reported sales of ₹14.27 Cr, up 14.3% from Jun 2025, and net profit of ₹0.20 Cr, down 85.2% year on year. For the year to Mar 2026, sales were ₹53.25 Cr and net profit −₹1.72 Cr.

Sales (Jun 2026): ₹14.27 Cr
Net profit (Jun 2026): ₹0.20 Cr
Sales (FY Mar 2026): ₹53.25 Cr
Net profit (FY Mar 2026): −₹1.72 Cr
EPS (Jun 2026): ₹0.10
Borrowings (Mar 2026): ₹67.43 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Vivo Bio Tech quarterly results

₹ crore unless stated; each column is a quarter.

Vivo Bio Tech Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	9.25	12.83	11.75	10.11	12.02	12.20	12.28	12.48	13.09	13.49	14.18	14.27
Expenses	4.42	6.50	6.41	5.79	6.47	6.70	7.29	7.05	7.72	8.05	9.78	9.27
Operating Profit	4.85	6.35	5.35	4.35	5.57	5.52	5.01	5.46	5.40	5.48	4.43	5.03
OPM %	52.5%	49.7%	45.7%	43.1%	46.5%	45.4%	40.9%	43.8%	41.4%	40.7%	31.4%	35.4%
Other Income	0.00	0.02	0.00	0.00	4.62	0.00	0.14	0.13	0.12	0.13	0.02	0.05
Interest	2.08	2.23	1.53	1.91	2.05	1.83	1.69	1.51	1.48	1.39	1.47	1.25
Depreciation	2.31	2.29	2.44	2.24	2.30	2.26	2.26	2.65	2.58	2.67	2.76	3.54
Profit before tax	0.46	1.89	1.42	0.21	5.86	1.45	1.23	1.47	1.50	1.56	0.24	0.33
Tax %	29.7%	31.0%	48.9%	27.2%	10.7%	43.8%	14.4%	9.4%	42.3%	20.3%	2,164.0%	44.1%
Net Profit	0.34	1.33	0.75	0.18	5.24	0.83	1.07	1.35	0.88	1.26	−5.17	0.20
EPS (Rs)	0.21	0.88	0.49	0.10	3.50	0.50	0.61	0.66	0.38	0.56	−2.32	0.10

Vivo Bio Tech profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Vivo Bio Tech Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	28.55	34.07	46.91	55.80	55.24	51.71	51.29	52.17	45.41	46.63	53.25	55.03
Expenses	24.94	26.59	36.26	46.46	43.03	34.10	35.41	30.51	24.28	26.19	32.58	34.82
Operating Profit	3.70	7.60	10.85	9.49	12.43	17.74	16.03	21.77	21.19	20.51	20.78	20.34
OPM %	13.1%	22.4%	23.3%	17.1%	22.6%	34.4%	31.4%	41.9%	46.8%	44.1%	39.2%	37.0%
Other Income	0.88	0.39	0.12	0.00	0.04	0.07	0.09	0.03	0.03	4.79	0.43	0.32
Interest	0.48	1.28	2.38	2.63	3.09	3.68	4.26	7.98	7.96	7.56	5.84	5.59
Depreciation	3.36	3.92	4.66	5.08	5.19	5.61	7.48	9.31	9.32	9.05	10.67	11.55
Profit before tax	0.77	2.82	4.00	1.81	4.24	8.61	4.46	4.61	4.05	8.78	4.80	3.63
Tax %	−16.8%	11.6%	21.9%	−23.1%	−4.5%	34.1%	50.7%	42.6%	37.9%	17.1%	135.5%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.01	0.00	—
Net Profit	0.92	2.51	3.13	2.26	4.45	5.69	2.21	2.66	2.54	7.30	−1.72	−2.83
EPS (Rs)	0.96	2.68	3.16	1.81	3.44	4.22	1.53	1.77	1.69	4.23	−0.76	−1.28
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Vivo Bio Tech balance sheet

₹ crore, at each year end.

Vivo Bio Tech Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.38	9.39	9.38	9.89	12.40	12.93	13.47	14.32	14.96	14.96	17.23	22.26
Reserves	−0.19	0.72	3.23	9.48	14.97	20.19	29.20	32.99	37.06	39.61	60.88	71.15
Borrowings	5.70	16.93	27.09	25.16	21.72	24.40	30.98	67.61	62.47	73.13	54.06	67.43
Other Liabilities	26.62	18.72	11.52	15.16	6.40	6.29	6.06	7.95	8.81	9.72	11.34	17.93
Total Liabilities	41.51	45.76	51.22	59.69	55.49	63.81	79.71	123	123	137	144	179
Fixed Assets	19.73	23.59	28.65	27.75	30.09	35.08	52.18	95.49	89.07	80.54	88.44	123
CWIP	0.08	0.05	2.95	3.95	0.08	0.14	0.31	0.88	1.91	9.20	12.85	4.82
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.87
Other Assets	21.70	22.12	19.62	27.99	25.32	28.59	27.22	26.50	32.32	47.68	42.22	28.76
Inventories	4.70	4.09	4.57	7.61	8.26	10.61	13.32	9.84	7.98	8.80	7.81	8.17
Trade receivables	4.30	3.81	7.66	11.77	8.40	10.49	7.28	12.01	12.39	11.81	11.26	11.74
Cash & equivalents	10.53	11.82	1.18	4.14	0.55	1.02	1.16	1.70	1.36	1.38	1.27	1.43
Total Assets	41.51	45.76	51.22	59.69	55.49	63.81	79.71	123	123	137	144	179

Vivo Bio Tech cash flow

₹ crore, for each year.

Vivo Bio Tech Cash flow
	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from operating activity	—	2.26	8.84	−5.68	11.15	−0.79	8.64	14.23	16.70	14.88	15.58	11.87
Cash from investing activity	—	−2.03	−7.18	−11.80	−4.70	−3.51	−10.19	−22.73	−50.91	−3.98	−7.92	−15.78
Cash from financing activity	—	−0.90	−0.33	6.86	−3.45	0.73	2.10	8.81	35.16	−11.22	−7.59	3.91
Net cash flow	—	−0.67	1.29	−10.64	2.95	−3.58	0.46	0.13	0.54	−0.33	0.00	−0.10
Capex	1.43	2.05	7.21	11.85	4.73	3.54	10.24	22.85	51.13	4.01	7.96	22.28
Free cash flow	—	0.20	1.60	−17.46	6.38	−4.30	−1.61	−8.62	−34.42	10.81	7.56	−4.00
CFO / OP %	—	81.0%	234.0%	−70.0%	110.0%	−13.0%	68.0%	96.0%	118.0%	77.0%	80.0%	65.0%

Vivo Bio Tech ratios

Working-capital days and returns, by year.

Vivo Bio Tech Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	87	48	81	90	54	68	50	84	86	94	87	79
Inventory days	559	170	205	290	257	452	673	314	431	832	492	367
Days payable	813	362	241	303	151	166	69	73	50	99	61	87
Cash conversion cycle	−168	−145	44	77	159	354	653	324	466	826	517	358
Working capital days	−354	−131	19	−13	36	35	29	8	38	64	100	−22
ROCE %	4.7%	6.0%	12.3%	15.2%	9.5%	13.8%	18.8%	9.3%	11.0%	9.9%	9.1%	7.3%

Vivo Bio Tech: frequently asked questions

What are the latest quarterly results of Vivo Bio Tech?

For the Jun 2026 quarter, Vivo Bio Tech reported sales of ₹14.27 Cr, up 14.3% year on year and net profit of ₹0.20 Cr, down 85.2% year on year. The operating margin was 35.4%.

What is the annual revenue of Vivo Bio Tech?

Vivo Bio Tech's sales for the year to Mar 2026 were ₹53.25 Cr; over the last twelve months they were ₹55.03 Cr.

What is the net profit of Vivo Bio Tech?

Net profit for the year to Mar 2026 was −₹1.72 Cr, and −₹2.83 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.28.

How much debt does Vivo Bio Tech have?

Vivo Bio Tech reported borrowings of ₹67.43 Cr at Mar 2026, against cash and equivalents of ₹1.43 Cr.

What is the free cash flow of Vivo Bio Tech?

Cash from operations was ₹11.87 Cr in the year to Mar 2025; after capital spending, free cash flow was −₹4 Cr.

Loading…